Skip to content

+1 877 566 4981

info@fdamap.com

Icon-instagram-1 X-twitter Icon-facebook Icon-linkedin
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • NDA Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us
Contact Us
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • NDA Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us

Day: July 5, 2018

FDA is Hiring A Lot of New Reviewers and Managers at Higher Salaries

April 17, 2025July 5, 2018 by Prahsant Kumar

About 40% of FDA’s senior leadership will be eligible to retire next year and about 15% of its overall workforce of 17,000 employees could also be eligible to retire. And that has FDA very worried about replenishing the talent. In an effort to hire more aggressively not only to prepare for the possible large-scale loss … Read more

Categories Blog

Is FDA Recall Process Too Slow To Protect Consumers? Victims Blame FDA

April 17, 2025July 5, 2018 by Prahsant Kumar

FDA is responsible to monitor and warn consumers about food borne infections to prevent illnesses, but it could take weeks and even months between when FDA becomes aware of a contaminated food and when the recall process begins. And during that time unsuspecting consumers could keep buying the tainted food and get sick. In an … Read more

Categories Blog

Recent Posts

  • From In silico to In vivo: Orchestrating AI for Breakthrough Therapeutics
  • Navigating the Hallucination Risks of Regulatory AI
  • Beyond the P-Value: Navigating the FDA’s New Bayesian Guidance for Drugs and Biologics
  • The Lean IND: Operationalizing the “Least Burdensome” Mandate
  • Beyond the LAL: Critical Updates to Bacterial Endotoxins and Pyrogen Testing

Recent Comments

No comments to show.

One-stop source for FDA consultation, regulatory affairs training, and clinical trial services.

Icon-instagram-1 X-twitter Icon-facebook Icon-linkedin

Services

  • Webinars
  • Workshops
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions

Company

  • About Us
  • Our Client
  • Testimonials
  • Free Resources
  • Newsletter

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy

Payment Method

100% Secure Transaction

Copyright © 2025 FDAMap.com. All rights reserved.